Papillary thyroid cancer (PTC) represents 80%-85% of thyroid cancer and its prevalence has been rising in the last decades. Primary thyroid lymphoma (PTL) accounts for 3% of extranodal lymphomas and about 5% of thyroid malignancies, Patients with thyroid nodules should be properly evaluated with ultrasound and thyroid function tests. If there is an enlargement of the neck, reported by symptoms or ultrasound, it requires further investigation. HT is associated to both PTC and PTL so if the enlargement of the nodules is on this context additional tests such as FNA should be performed. In this case, the patient was managed with surgery and radioactive iodine ablation therapy and it was effective for both entities.
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Patients with thyroid nodules should be properly evaluated with ultrasound and thyroid function tests. If there is an enlargement of the neck, reported by symptoms or ultrasound, it requires further investigation. HT is associated to both PTC and PTL so if the enlargement of the nodules is on this context additional tests such as FNA should be performed. In this case, the patient was managed with surgery and radioactive iodine ablation therapy and it was effective for both entities.
Introduction
Thyroid cancer represents 1% of all cancer cases in the United States and it's the most common endocrine malignancy. Papillary thyroid cancer (PTC) represents the most frequent variation at countries with iodine sufficient diet [1] and its prevalence has been rising in the last decades, being about 80%-85% [1, 2] . More common in women (2.4: 1), it has a peak between third and fifth decades of life [1] . Also, there are exogenous factors: radiation exposure, high-iodine diet, nitrates, western style life and endogenous factors high levels of thyroid stimulating hormone, Hashimoto's thyroiditis (HT) and obesity, associated with PTC [3] .
Primary thyroid lymphoma (PTL) accounts for 3% of extranodal lymphomas and about 5% of thyroid malignancies, having a prevalence of one to two cases per million people [4, 5] . More common in women (3:1) at seventh decade of life, it develops 5 to 10 years earlier in men [4] . Its pathogenesis is unknown, but PTL, autoimmune diseases and antigen stimulation have been associated. Patients with HT have 40-80 times more risk, however only 0, 6% develop it [6, 7] . It has been proposed that lymphoid tissue develops
in the thyroid in a context of a long standing HT into a Mucosa-Associated Lymphoid Tissue (MALT) lymphoma [4] .
Case report
A 54-year-old man followed-up due to a goiter enlargement in last nine months, now presents with associated cervical pain, dysphonia and dysphagia to solids. The patient is a former smoker, denies exposition to other toxic agents. He does not have family history of thyroid cancer. His father died of gastric cancer and one son has hypothyroidism. On physical examination, thyroid gland was enlarged asymmetrically.
The left lobe was larger than the right and it had a nodule of 4 cm, soft, delimited, not adhered to deep tissue and motile at deglutition. A nodule of 2 cm with the same characteristics was found at right lobe. There was no palpable cervical lymphadenopathy and the rest of the examination and laboratory results were unremarkable. The patient was euthyroid and he didn't take any medication. Figure 1D ) and negativity to CD3, CD10, BCL6 and thyroglobulin. Proliferation rate (Ki67) was 15%-20%. The remaining thyroid parenchyma revealed remains of HT.
The patient was discharged home and prescribed levothyroxine 100 mcg. Two months later surveillance tests were performed, consisting of upper endoscopy, computed tomography of neck, thorax, abdomen and pelvis, bone scintigraphy and bone marrow biopsy. They didn't show any evidence of disease. Two months later the patient had ablation therapy with 80mCi of I 131 after withdrawal from thyroid hormone. There was no evidence of disease on his last visit.
Discussion
The coexistence of MALT lymphoma and PTC in a context of HT is extremely uncommon, with few cases reported [8] [9] [10] . Clinical presentation of these cases is variable.
The course can be indolent and only detected by thyroid ultrasound, as the experiences of Cheng et al [10] and Vassilatou et al [11] or, more typical of PTL, an enlargement of a neck mass [6] that can be with obstructive symptoms as hoarseness [8] , dysphonia, neck pain and dysphagia as the present patient or even severe airway obstruction leading to emergency surgery [12] , or without them, an isolated enlargement [9] .
The diagnosis of these entities can be achieved with thyroid ultrasound and fine needle aspiration (FNA), thyroid biopsy or after thyroidectomy. Thyroid laboratory workup can result in euthyroid without medication [8, 9, 12] as this patient, subclinical hyperthyroidism [11] or hypothyroidism (if untreated). Therapeutic approach in cases like M A N U S C R I P T
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PTC is the most frequent thyroid cancer and it's managed with surgery and radioactive iodine, therapy is curative often. Generally, it doesn't metastases out of the neck (5%-7%) and is rare as a cause of death. The following workup includes full body scan, neck ultrasound, levels of thyroglobulin and anti-thyroglobulin antibodies [1, 2, 13] .
A fast growing goiter should make suspect of PTL and even more if there are associated cervical lymphadenopathies. FNA sample should be used for cytology, flow cytometry and immunohistochemistry to determine the type because it changes the management and prognosis [6] .
Diffuse large B-cell lymphoma represents nearly 70% of PTL and has a more aggressive course. Its treatment consists of combined schemes of rituximab, chemotherapy and radiotherapy; the disease free survival is almost 75% at 5 years, while MALT lymphoma has a better prognosis, with a disease free survival of near 96%
at 5 years and its treated with surgery and radiotherapy either alone or in combination.
Radiotherapy alone has a success of 70%-100%, while thyroidectomy is risky, has not demonstrated to increase overall survival and is reserved for cases with obstructive impairment [4] .
The mechanism that may associate HT with these two entities is yet to be determined.
Nevertheless, the autoimmune process and antigen exposure seem to have an important role in the pathogenesis [4] . Total thyroidectomy represented an effective measure at experience of Cheng et al [10] and Melo et al [9] , with six years and two years without recurrence respectively [12] . There is not information about long term effects so appropriate surveillance must be done. This report adds information about the M A N U S C R I P T
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